Imagion Biosystems: Edison Open House Healthcare 2022

Imagion Biosystems: Edison Open House Healthcare 2022

Imagion Biosystems Limited manufactures and supplies medical equipment. The Company offers a bio-imaging detection technology that uses disease specific targeting nanoparticles and highly sensitive detectors to locate tumors and other diseased cells by their molecular signature.

• Tell us about MagSense and its advantages.
• Can this process be used with existing magnetic resonance imaging (MRI) machines?
• Do you see MagSense being used as a screening or a diagnostic tool?
• Do you believe the use of this product could extend beyond breast and prostate cancer?
• Are there potential cost-saving opportunities?
• What is your market strategy?
• Is your product affected by the global shortage of radiologists and other professionals required to read traditional MRI images?
• Which milestones should investors focus on in the coming year?


You may also be interested in these:

Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.